Atomistry » Chlorine » PDB 6zc8-6zp8 » 6zgw
Atomistry »
  Chlorine »
    PDB 6zc8-6zp8 »
      6zgw »

Chlorine in PDB 6zgw: Structure of Human Galactokinase 1 Bound with (4-Chlorophenyl)Methyl Pyridine-3-Carboxylate

Enzymatic activity of Structure of Human Galactokinase 1 Bound with (4-Chlorophenyl)Methyl Pyridine-3-Carboxylate

All present enzymatic activity of Structure of Human Galactokinase 1 Bound with (4-Chlorophenyl)Methyl Pyridine-3-Carboxylate:
2.7.1.6;

Protein crystallography data

The structure of Structure of Human Galactokinase 1 Bound with (4-Chlorophenyl)Methyl Pyridine-3-Carboxylate, PDB code: 6zgw was solved by S.R.Mackinnon, G.A.Bezerra, M.Zhang, W.Foster, T.Krojer, J.Brandao-Neto, A.Douangamath, C.Arrowsmith, A.Edwards, C.Bountra, P.Brennan, K.Lai, W.W.Yue, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 118.91 / 2.30
Space group P 1 21 1
Cell size a, b, c (Å), α, β, γ (°) 73.674, 114.560, 120.934, 90.00, 100.49, 90.00
R / Rfree (%) 20.9 / 25.5

Chlorine Binding Sites:

The binding sites of Chlorine atom in the Structure of Human Galactokinase 1 Bound with (4-Chlorophenyl)Methyl Pyridine-3-Carboxylate (pdb code 6zgw). This binding sites where shown within 5.0 Angstroms radius around Chlorine atom.
In total only one binding site of Chlorine was determined in the Structure of Human Galactokinase 1 Bound with (4-Chlorophenyl)Methyl Pyridine-3-Carboxylate, PDB code: 6zgw:

Chlorine binding site 1 out of 1 in 6zgw

Go back to Chlorine Binding Sites List in 6zgw
Chlorine binding site 1 out of 1 in the Structure of Human Galactokinase 1 Bound with (4-Chlorophenyl)Methyl Pyridine-3-Carboxylate


Mono view


Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 1 of Structure of Human Galactokinase 1 Bound with (4-Chlorophenyl)Methyl Pyridine-3-Carboxylate within 5.0Å range:
probe atom residue distance (Å) B Occ
D:Cl401

b:54.7
occ:1.00
CL1 D:QKW401 0.0 54.7 1.0
C1 D:QKW401 1.7 46.6 1.0
C13 D:QKW401 2.7 45.7 1.0
C2 D:QKW401 2.7 43.9 1.0
CD1 D:LEU40 2.9 34.8 1.0
CZ D:PHE303 3.5 29.8 1.0
CE1 D:PHE303 3.8 30.2 1.0
CE2 D:PHE303 3.9 28.9 1.0
C12 D:QKW401 4.0 44.8 1.0
CD1 D:LEU295 4.0 30.2 1.0
C3 D:QKW401 4.0 46.4 1.0
CD2 D:LEU295 4.1 30.5 1.0
CB D:ALA198 4.1 30.3 1.0
CG D:LEU40 4.2 30.9 1.0
CD2 D:LEU53 4.2 27.8 1.0
CD2 D:LEU213 4.3 33.3 1.0
CG D:LEU295 4.5 30.8 1.0
C4 D:QKW401 4.5 45.8 1.0
CD1 D:PHE303 4.6 30.6 1.0
CD2 D:PHE303 4.6 29.2 1.0
CB D:LEU40 4.7 29.5 1.0
CD2 D:LEU40 4.7 32.4 1.0
CD1 D:LEU213 4.9 35.0 1.0
CG D:PHE303 4.9 29.8 1.0

Reference:

S.R.Mackinnon, T.Krojer, W.R.Foster, M.Tang, F.Von Delft, K.Lai, P.Brennan, G.A.Bezerra, W.W.Yue. Fragment Screening Reveals Starting Points For Rational Design of Galactokinase 1 Inhibitors to Treat Classic Galactosemia To Be Published.
Page generated: Mon Jul 29 18:04:20 2024

Last articles

Zn in 9MJ5
Zn in 9HNW
Zn in 9G0L
Zn in 9FNE
Zn in 9DZN
Zn in 9E0I
Zn in 9D32
Zn in 9DAK
Zn in 8ZXC
Zn in 8ZUF
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy